Last reviewed: June 16, 2026
Last updated: June 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 supplements are prescription medications that activate receptors in your brain and gut to regulate appetite and blood sugar. Clinical trials show that semaglutide users lose an average of 15–22% of body weight over 68 weeks, making GLP-1 therapy one of the most effective weight management tools available today.
What Is GLP-1 and How Does It Work for Weight Loss?
GLP-1 stands for glucagon-like peptide-1, a hormone your body naturally produces after eating. This hormone signals your brain that you are full, slows stomach emptying, and helps regulate blood sugar levels. When GLP-1 receptor agonists are prescribed, they amplify these signals, leading to reduced appetite, fewer food cravings, and lower overall calorie intake without requiring extreme willpower.
The weight loss mechanism operates on multiple levels: decreased hunger signals travel from your gut to your brain, your stomach empties more slowly so you feel satisfied longer, and your body's energy regulation pathways become more efficient. Studies published in major medical journals confirm that people taking GLP-1 medications experience genuine shifts in how their bodies perceive hunger and fullness, not just temporary appetite suppression.
Compounded Semaglutide vs. Oral GLP-1 Options
Semaglutide is available in two forms through PlexusDx: as a compounded injection starting at $149 per month, or as an oral tablet starting at $249 per month. The injectable version is administered once weekly and typically produces faster, more consistent results because it bypasses digestion. Oral semaglutide offers convenience for needle-averse patients, though absorption can vary based on stomach contents and individual metabolism.
PlexusDx sources all compounded medications from licensed 503A compounding pharmacies, which operate under strict pharmaceutical standards and state board oversight. Your dose may need to go up as your body adjusts and your prescriber optimizes your therapy. Your price won't—PlexusDx pricing remains flat across all dose levels, ensuring affordability as your treatment evolves.
Genetic Testing for Personalized GLP-1 Therapy
Not every body responds identically to GLP-1 medications, and your genetic makeup plays a significant role in how well you lose weight and tolerate your dose. PlexusDx offers the Precision Peptide Genetic Test, a $99 add-on available after your first month of treatment, which analyzes 14 metabolic pathways and 150+ genetic insights. The test examines key variants like GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 to predict your peptide-pathway responsiveness.
Understanding your genetic predispositions helps your PlexusDx provider fine-tune your medication selection and dosing strategy. Patients with certain genetic profiles may achieve better outcomes with semaglutide, while others respond more strongly to tirzepatide (which activates both GLP-1 and GIP receptors). This precision approach eliminates guesswork and accelerates your path to sustainable weight loss.
How PlexusDx Makes GLP-1 Accessible and Affordable
PlexusDx delivers compounded GLP-1 medications to all 50 states without requiring insurance or membership fees. Treatment options range from the Microdose GLP-1 Protocol at $129 per month to dual-compound GLP-Squared formulations, ensuring there is a price point and medication strength for every patient's needs and budget. All medications are HSA and FSA eligible, further reducing your out-of-pocket costs.
The company's flat-pricing model means you never pay more as your prescriber increases your dose—a transparent approach that protects your budget while allowing your therapy to scale safely. PlexusDx also coordinates care with your doctor, providing ongoing support, side-effect management education, and regular check-ins to ensure you remain on track toward your weight loss goals.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is GLP-1 the same as a supplement, or is it a prescription medication?
GLP-1 medications are prescription-grade drugs, not dietary supplements. They require a valid prescription from a licensed healthcare provider and are sourced from licensed 503A compounding pharmacies. PlexusDx coordinates with your doctor to ensure safe dosing and ongoing monitoring throughout your treatment.
How quickly will I see weight loss results with semaglutide?
Most patients notice reduced appetite within the first 1–2 weeks of starting semaglutide. Measurable weight loss typically appears after 4–8 weeks, with momentum accelerating over 3–6 months as your body adapts and your dose optimizes. Clinical trials show average weight loss of 15–22% over 68 weeks, though individual results vary based on genetics, lifestyle, and dose adherence.
What does PlexusDx charge for compounded semaglutide injections?
PlexusDx offers compounded semaglutide injections starting at $149 per month on a flat-rate pricing model. Your dose may increase over time as your prescriber titrates your therapy, but your monthly price remains fixed—you will never pay more for a higher dose. All medications come from licensed 503A compounding pharmacies and are available nationwide without insurance.
What are the common side effects of GLP-1 medications?
The most frequently reported side effects are mild nausea, constipation, and reduced appetite—which actually contributes to weight loss. These effects typically diminish after the first 2–4 weeks as your body adjusts. Serious side effects are rare but can include pancreatitis or gallbladder issues; PlexusDx providers monitor your health throughout treatment and educate you on warning signs to watch for.
How does the Precision Peptide Genetic Test help me choose between semaglutide and tirzepatide?
PlexusDx's Precision Peptide Genetic Test analyzes your response patterns across 14 metabolic pathways, examining variants in GLP1R, GIPR, FTO, and MC4R genes. Results reveal whether your genetics predict stronger activation of GLP-1 pathways alone (favoring semaglutide) or dual GLP-1/GIP activation (favoring tirzepatide), helping your provider select the medication with the highest probability of success for your unique biology.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can Stopping Ozempic Cause Side Effects? Understanding the Impacts of Discontinuation
Navigating Weight Loss: What to Take Instead of Wegovy